Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
Incyte Corporation
University of Miami
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
H. Lee Moffitt Cancer Center and Research Institute
Thomas Jefferson University
M.D. Anderson Cancer Center
Goethe University
Thomas Jefferson University
French Innovative Leukemia Organisation
University of Arizona
Thomas Jefferson University
Stanford University
University of California, San Diego
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Center for International Blood and Marrow Transplant Research
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
Cancer Trials Ireland
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Amgen
National Institutes of Health Clinical Center (CC)
Institute of Hematology & Blood Diseases Hospital, China
Janssen Research & Development, LLC
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
University College, London
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
German CLL Study Group
Universitätsklinikum Hamburg-Eppendorf
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Stanford University
St. Petersburg State Pavlov Medical University